Literature DB >> 4110596

Effect of Sotalol on clinical arrhythmias.

R Prakash, W W Parmley, H N Allen, J M Matloff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4110596     DOI: 10.1016/0002-9149(72)90537-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

Review 1.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Sotalol in patients with life-threatening ventricular tachyarrhythmias.

Authors:  H J Trappe; H Klein; P Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

3.  Efficacy of sotalol in controlling reentrant supraventricular tachycardias.

Authors:  R N Millar
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 4.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Authors:  Jordi Heijman; Vincent Algalarrondo; Niels Voigt; Jonathan Melka; Xander H T Wehrens; Dobromir Dobrev; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2015-12-23       Impact factor: 10.787

5.  Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise.

Authors:  V Hombach; V Braun; H W Höpp; D Gil-Sanchez; D W Behrenbeck; M Tauchert; H H Hilger
Journal:  Klin Wochenschr       Date:  1981-02-02

6.  Oral N-acetylprocainamide compared to quinidine plus digoxin in the chronic suppression of atrial flutter in humans.

Authors:  G K Feld; K Nademanee; E Noll; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.